147 related articles for article (PubMed ID: 38281758)
1. Comparative pharmacokinetics of tyrosine kinase inhibitor, lapatinib, in dogs and cats following single oral administration.
Yu TW; Yamamoto H; Morita S; Fukushima R; Elbadawy M; Usui T; Sasaki K
J Vet Med Sci; 2024 Mar; 86(3):317-321. PubMed ID: 38281758
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines.
Sakai K; Maeda S; Saeki K; Nakagawa T; Murakami M; Endo Y; Yonezawa T; Kadosawa T; Mori T; Nishimura R; Matsuki N
Vet Comp Oncol; 2018 Dec; 16(4):642-649. PubMed ID: 30246405
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.
Hamlin AN; Chadwick LE; Fox-Alvarez SA; Hostnik ET
Vet Radiol Ultrasound; 2019 Sep; 60(5):552-559. PubMed ID: 31144408
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration.
Kilp S; Ramirez D; Allan MJ; Roepke RK
Parasit Vectors; 2016 May; 9(1):296. PubMed ID: 27241240
[TBL] [Abstract][Full Text] [Related]
5. Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.
Maeda S; Sakai K; Kaji K; Iio A; Nakazawa M; Motegi T; Yonezawa T; Momoi Y
Sci Rep; 2022 Jan; 12(1):4. PubMed ID: 35027594
[TBL] [Abstract][Full Text] [Related]
6. Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor.
Spector NL; Robertson FC; Bacus S; Blackwell K; Smith DA; Glenn K; Cartee L; Harris J; Kimbrough CL; Gittelman M; Avisar E; Beitsch P; Koch KM
PLoS One; 2015; 10(11):e0142845. PubMed ID: 26571496
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
Medina PJ; Goodin S
Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of minocycline in domestic cats.
Tynan BE; Papich MG; Kerl ME; Cohn LA
J Feline Med Surg; 2016 Apr; 18(4):257-63. PubMed ID: 25851119
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
Yancey MF; Merritt DA; Lesman SP; Boucher JF; Michels GM
J Vet Pharmacol Ther; 2010 Apr; 33(2):162-71. PubMed ID: 20444041
[TBL] [Abstract][Full Text] [Related]
10. Neoplasms of the canine and feline urinary bladder: incidence, etiologic factors, occurrence and pathologic features.
Osborne CA; Low DG; Perman V; Barnes DM
Am J Vet Res; 1968 Oct; 29(10):2041-55. PubMed ID: 5692896
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus).
Smith JS; Gebert JE; Ebner LS; Bennett KO; Collins RJ; Hampton CE; Kleine SA; Mulon PY; Smith CK; Seddighi R; Bussieres G; Mochel JP; Knych HK
J Vet Pharmacol Ther; 2023 May; 46(3):158-164. PubMed ID: 36872454
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs.
Sarasola P; Jernigan AD; Walker DK; Castledine J; Smith DG; Rowan TG
J Vet Pharmacol Ther; 2002 Aug; 25(4):265-72. PubMed ID: 12213114
[TBL] [Abstract][Full Text] [Related]
13. Single- and multiple-dose pharmacokinetics of sotalol hydrochloride in healthy cats.
Salmon SJ; Coleman AE; Lynn CR; Sanders JE; Messenger KM
J Vet Cardiol; 2024 Feb; 51():86-96. PubMed ID: 38118234
[TBL] [Abstract][Full Text] [Related]
14. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of bacteria from feline and canine urinary tract infections to doxycycline and tetracycline concentrations attained in urine four hours after oral dosage.
Wilson BJ; Norris JM; Malik R; Martin PA; Wigney DI; Baral RM; Govendir M
Aust Vet J; 2006; 84(1-2):8-11. PubMed ID: 16498827
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of single oral dose extended-release topiramate and adverse effects after multi-dose administration in healthy cats.
Graham LT; Foss KD; Reinhart JM; Smith KM; Hague DW; Li Z
J Vet Pharmacol Ther; 2023 Jul; 46(4):218-228. PubMed ID: 36872425
[TBL] [Abstract][Full Text] [Related]
17. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H
Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Single-Dose Oral Pregabalin Administration in Normal Cats.
Esteban MA; Dewey CW; Schwark WS; Rishniw M; Boothe DM
Front Vet Sci; 2018; 5():136. PubMed ID: 30079339
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of pseudoephedrine in rats, dogs, monkeys and its pharmacokinetic-pharmacodynamic relationship in a feline model of nasal congestion.
Palamanda JR; Mei H; Morrison R; McLeod RL; McCormick K; Corboz M; Xu X; Korfmacher W; Broske L; Nomeir AA
Drug Metab Lett; 2010 Apr; 4(2):56-61. PubMed ID: 20446910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
